The German Federal Patent Court has set aside a decision by the German Patent and Trade Mark Office (DPMA) to reject a supplementary protection certificate (SPC) that GSK Biologicals had applied for, in a decision of “fundamental importance”.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at firstname.lastname@example.org
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
German Federal Patent Court, German Patent and Trademark Office, patent, supplementary protection certificate, Hoffmann Eitle, Bianca-Lucia Vos, Klemens St